CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action – HBSS

Posted on by sHq_LoGiNz

SAN FRANCISCO–(BUSINESS WIRE)—- $CAPR #CAPR–Hagens Berman is investigating claims in a class action complaint filed on behalf of investors in Capricor Therapeutics (CAPR) against the Company.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.